In 2025, Mass Appeal launched the Legend Has It...campaign that repackages hip-hop class acts as a label asset class and long ...

In 4 completed studies and the ongoing OL study, 65 participants received at least 1 dose of nomlabofusp, including 39 in the OL study, with 14 on treatment for at least 6 months and 8 for over 1 year ...

MUMBAI, India and PRINCETON, N.J., Nov. 25, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

Footwear retailer Designer Brands announced on Friday a long-term plan that includes leveraging its focus on customers, building brands and optimizing speed to drive growth, according to a company ...

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Extends Pediatric Psoriasis Study: What ...

The Food and Drug Administration Project PAUSE will hold a workshop exploring black box warnings on antipsychotic medication instructions, especially for older adults. The team’s directives came from ...

As the first and only PD-L1 immune checkpoint inhibitor approved for aCSCC, UNLOXCYT is an evolution in checkpoint inhibition, offering a balance of durable clinical responses and acceptable ...